Drug Discovery and Development Analysis & Statistics, July 2014 (p35)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

All regions

You might be interested in: clinical trial, drug discovery, drug development, more »

1021-1060 of about 3 200 reports

Purchase Reports From Reputable Market Research Publishers

Peroxisome Proliferator-Activated Receptor (PPAR) Agonists -Pipeline Insights, 2014

Peroxisome Proliferator-Activated Receptor (PPAR) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Peroxisome Proliferator-Activated Receptor (PPAR) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Phosphodiesterase (PDE) Inhibitors -Pipeline Insights, 2014

Phosphodiesterase (PDE) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Phosphodiesterase (PDE) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Phosphoinositide 3-Kinase Alpha (PI3K Alpha) Inhibitors -Pipeline Insights, 2014

Phosphoinositide 3-Kinase Alpha (PI3K Alpha) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Phosphoinositide 3-Kinase Alpha (PI3K Alpha) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitors -Pipeline Insights, 2014

Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitors -Pipeline Insights, 2014

Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Phospholipase C Inhibitors -Pipeline Insights, 2014

Phospholipase C Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Phospholipase C Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
PI3K/AKT/mTOR Pathway Inhibitors -Pipeline Insights, 2014

PI3K/AKT/mTOR Pathway Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“PI3K/AKT/mTOR Pathway Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
PI3K-AKT Signaling Pathway Inhibitors -Pipeline Insights, 2014

PI3K-AKT Signaling Pathway Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“PI3K-AKT Signaling Pathway Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Pim Kinase 1 (PIM-1) Inhibitors -Pipeline Insights, 2014

Pim Kinase 1 (PIM-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Pim Kinase 1 (PIM-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Pim Kinase 2 (PIM-2) Inhibitors -Pipeline Insights, 2014

Pim Kinase 2 (PIM-2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Pim Kinase 2 (PIM-2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Pim Kinase 3 (PIM-3) Inhibitors -Pipeline Insights, 2014

Pim Kinase 3 (PIM-3) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Pim Kinase 3 (PIM-3) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Placental Growth Factor (PIGF) Blockers -Pipeline Insights, 2014

Placental Growth Factor (PIGF) Blockers -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Placental Growth Factor (PIGF) Blockers-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Plasmin Inhibitors -Pipeline Insights, 2014

Plasmin Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Plasmin Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Polo-Like Kinase 1 (PLK1 )Inhibitors -Pipeline Insights, 2014

Polo-Like Kinase 1 (PLK1 )Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Polo-Like Kinase 1 (PLK1 )Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Polo-Like Kinase 2 (PLK2) Inhibitors -Pipeline Insights, 2014

Polo-Like Kinase 2 (PLK2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Polo-Like Kinase 2 (PLK2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Poly (ADP-Ribose) Polymerase 1 (PARP-1) Inhibitors -Pipeline Insights, 2014

Poly (ADP-Ribose) Polymerase 1 (PARP-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Poly (ADP-Ribose) Polymerase 1 (PARP-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Poly (ADP-Ribose) Polymerase 2 (PARP-2) Inhibitors -Pipeline Insights, 2014

Poly (ADP-Ribose) Polymerase 2 (PARP-2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Poly (ADP-Ribose) Polymerase 2 (PARP-2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
PPAR-Beta / Delta Agonists -Pipeline Insights, 2014

PPAR-Beta / Delta Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“PPAR-Beta / Delta Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Prolactin Receptor Antagonists -Pipeline Insights, 2014

Prolactin Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prolactin Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors -Pipeline Insights, 2014

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug Discovery and Development
Prostaglandin Antagonists -Pipeline Insights, 2014

Prostaglandin Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Agonists -Pipeline Insights, 2014

Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Drug Discovery and Development
Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Antagonists -Pipeline Insights, 2014

Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Drug Discovery and Development
Prostaglandin E Receptor 2 (EP2 or Prostaglandin E2 Receptor EP2 Subtype) Agonists -Pipeline Insights, 2014

Prostaglandin E Receptor 2 (EP2 or Prostaglandin E2 Receptor EP2 Subtype) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin E Receptor 2 (EP2 or Prostaglandin E2 Receptor EP2 Subtype) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Drug Discovery and Development
Prostaglandin E2 (PGE2) Receptor Antagonists -Pipeline Insights, 2014

Prostaglandin E2 (PGE2) Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin E2 (PGE2) Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Prostaglandin F2-Alpha Receptor (PGF receptor or Prostanoid FP Receptor) Antagonists -Pipeline Insights, 2014

Prostaglandin F2-Alpha Receptor (PGF receptor or Prostanoid FP Receptor) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin F2-Alpha Receptor (PGF receptor or Prostanoid FP Receptor) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Drug Discovery and Development
Prostaglandin F2-Alpha Receptor Agonists -Pipeline Insights, 2014

Prostaglandin F2-Alpha Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin F2-Alpha Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Purine Nucleoside Phosphorylase (PNPase) Inhibitors -Pipeline Insights, 2014

Purine Nucleoside Phosphorylase (PNPase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Purine Nucleoside Phosphorylase (PNPase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Purinergic Receptor (Purinoceptor) Antagonists -Pipeline Insights, 2014

Purinergic Receptor (Purinoceptor) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Purinergic Receptor (Purinoceptor) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Pyrimidine Analogues -Pipeline Insights, 2014

Pyrimidine Analogues -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Pyrimidine Analogues-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development

82 Companies

Read our Company Profiles

Pfizer Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.